Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults

Data on the safety and immunity of a heterologous booster (fourth dose) after three-doses of inactivated SARS-CoV-2 vaccine in Chinese adults are limited. We evaluate the safety and immunogenicity of Ad5-nCoV in a randomized, double-blind, parallel-controlled phase 4 clinical trial in Zhejiang, Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hangjie, Xu, Nani, Xu, Yu, Qin, Pan, Dai, Rongrong, Xu, Bicheng, Wang, Shenyu, Ding, Linling, Fu, Jian, Zhang, Shupeng, Hua, Qianhui, Liao, Yuting, Yang, Juan, Hu, Xiaowei, Jiang, Jianmin, Lv, Huakun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409730/
https://www.ncbi.nlm.nih.gov/pubmed/37553338
http://dx.doi.org/10.1038/s41467-023-40489-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409730/
https://www.ncbi.nlm.nih.gov/pubmed/37553338
http://dx.doi.org/10.1038/s41467-023-40489-2

Ejemplares similares